PortViewPortView
Purple Biotech logo

Purple Biotech (PPBT) Stock Analysis

NASDAQHealthcareBiotechnology

$2.24+34.94%
1-year price historyRange $1.33 – $14.20
52-week range$2.24
$1.16$14.89

What Purple Biotech does

Purple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). This candidate is undergoing Phase 1b/2 clinical trials, where it is being evaluated as a combination therapy with anti-PD-1 checkpoint inhibitors for non-small cell lung cancer and pancreatic cancer. NT219: A small molecule compound that targets insulin receptor substrate 1 and 2 (IRS1/2) as well as signal transducer and activator of transcription (STAT) pathways. NT219 is currently in Phase 1/2 clinical studies for the treatment of recurrent or metastatic solid tumors and squamous cell carcinoma of the head and neck. The company was formerly known as Kitov Pharma Ltd until its rebranding to Purple Biotech Ltd. in December 2020.

Key metrics

Market cap
$309,308
P/E (TTM)
-0.11
EPS (TTM)
$-20.63
Beta
-0.54
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$1.55
200-day avg
$4.29
52-week high
$14.89
52-week low
$1.16
CEO
Gil Efron

ETFs linked to PPBT

Broad-market and Healthcare sector ETFs an investor holding Purple Biotech is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PPBT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PPBT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Purple Biotech?
Purple Biotech trades under the ticker PPBT on NASDAQ.
Which exchange is PPBT listed on?
PPBT is listed on NASDAQ.
What sector does Purple Biotech operate in?
Purple Biotech is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PPBT in a portfolio?
PortView shows PPBT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.